Amalus Therapeutics

Ghent, Belgium

Amalus Therapeutics' objective is to significantly improve the lives of those suffering from cancer and fibrotic disorders

$542K raised

Aug 2023

Convertible Note

Biotechnology Health Care

Top Investors

BioInnovation Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amalus Therapeutics

How much funding has Amalus Therapeutics raised?

Amalus Therapeutics has raised $542K in total funding. The most recent round was Convertible Note. The last funding was announced in August 2023.

Who are Amalus Therapeutics's investors?

Amalus Therapeutics's investors include BioInnovation Institute.

Where is Amalus Therapeutics headquartered?

Amalus Therapeutics is headquartered in Ghent, Belgium.

What does Amalus Therapeutics do?

Amalus Therapeutics' objective is to significantly improve the lives of those suffering from cancer and fibrotic disorders

What stage is Amalus Therapeutics at?

Amalus Therapeutics is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 31, 2023.

MLA

"Amalus Therapeutics — Funding & Investors." VCBacked, August 31, 2023, https://www.vcbacked.co/company/amalus-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Amalus Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amalus-therapeutics

Wikipedia (cite web)

{{cite web |title=Amalus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amalus-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 31, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K